Diferencia entre revisiones de «Metabolic dysfunction-associated steatohepatitis (MASH)»

Línea 21: Línea 21:
*[[LFTs]], CBC
*[[LFTs]], CBC
*[[RUQ US]]
*[[RUQ US]]
*Outpatient elastography/Fibroscan


==Management==
==Management==

Revisión del 07:09 18 ago 2022

Background

  • Fatty liver disease due to causes other than excessive alcohol
  • Associated with insulin resistance and metabolic syndrome

Clinical Features

Differential Diagnosis

Evaluation

  • LFTs, CBC
  • RUQ US
  • Outpatient elastography/Fibroscan

Management

  • Treat complications of portal hypertension, if present

Disposition

  • Discharge unless complications

See Also

External Links

References